Refractory Angina: Clinical Trials

8 trials for Refractory Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 suspended, 1 unknown. 8 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 3, Recruiting 2, Suspended 1, Unknown 1, Withdrawn 1
Phase 11Completed 1
Phase 31Unknown 1

Follow Refractory Angina: new trials by email Literature Review of Refractory Angina trials Research Report on Refractory Angina

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
XC001, Sham (No Treatment) - Refractory Angina, Coronary Artery Disease
Phase 2RecruitingXyloCor Therapeutics, Inc.1062025-07-082026-09-11
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells., Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath). - Refractory Angina Pectoris, Refractory Angina
Phase 2RecruitingBarts & The London NHS Trust1102024-03-012026-01-07
Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms
Allopurinol 300 MG, Placebo oral tablet - Refractory Angina
Phase 2 / Phase 3UnknownMinistry of Health, Brazil402021-03-032021-02-24
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina
IMB-1018972, Placebo oral tablet - Refractory Angina
Phase 2WithdrawnImbria Pharmaceuticals, Inc.2020-05-012025-11-10
Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
Neovasc Reducer, Control - Refractory Angina
Phase 2CompletedShockwave Medical, Inc.1042010-09-012013-11-25
Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis
Selected CD 133+ cells - Coronary Artery Disease, Refractory Angina
Phase 1 / Phase 2CompletedPilar Jimenez Quevedo282008-05-012013-08-06
Intramyocardial Delivery of Autologous Bone Marrow
Mononuclear bone marrow derived cells - Refractory Angina
Phase 2SuspendedIRCCS San Raffaele132007-05-012012-02-02
Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina
Local sedation, Bone Marrow Aspiration, Minithoracotomy - Refractory Angina
Phase 2CompletedCellPraxis Bioengenharia Ltda.132005-07-012014-06-03

Narrower conditions

Angina Pectoris (8)  ·  Coronary Artery Disease (3)  ·  Myocardial Ischemia (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Chest Pain (8)  ·  Heart Diseases (8)  ·  Neurologic Manifestations (8)  ·  Pain (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Vascular Diseases (8)  ·  Myocardial Ischemia (7)  ·  Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Coronary Disease (3)

Interventions

Allopurinol (1)  ·  salicylhydroxamic acid (1)

Sponsors

Barts & The London NHS Trust (1)  ·  CellPraxis Bioengenharia Ltda. (1)  ·  IRCCS San Raffaele (1)  ·  Imbria Pharmaceuticals, Inc. (1)  ·  Ministry of Health, Brazil (1)  ·  Pilar Jimenez Quevedo (1)  ·  Shockwave Medical, Inc. (1)  ·  XyloCor Therapeutics, Inc. (1)

Countries

Brazil (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Anthony Mathur (1)  ·  Enio Buffolo, MD, PhD (1)  ·  Luis Henrique W Gowdak, MD, PhD (1)  ·  Nelson A Hossne Junior, MD, PhD (1)  ·  Paul Chamberlin, MD (1)  ·  Pilar Jimenez-Quevedo, MD,PhD (1)  ·  Stefan Verheye, MD (1)  ·  Tim Henry, MD (1)

Results publications

PMID 16990385, PMID 23413981, PMID 25651246, PMID 32719097, PMID 38862073

NIH funding

2018 (1)